Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)

每日一次添加利西拉来治疗通过既定基础胰岛素控制不佳的 2 型糖尿病：一项为期 24 周的随机安慰剂对照研究 (GetGoal-L)